Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease
Shu Dong, Zong-Ying Zhan, Hongyan Cao, et al.
World Journal of Gastroenterology (2017) Vol. 23, Iss. 15, pp. 2771-2771
Open Access | Times Cited: 62

Showing 26-50 of 62 citing articles:

Serum untargeted metabolomics delineates the metabolic status in different subtypes of non-alcoholic fatty liver disease
Liyan Liu, Jinhui Zhao, Runan Zhang, et al.
Journal of Pharmaceutical and Biomedical Analysis (2021) Vol. 200, pp. 114058-114058
Closed Access | Times Cited: 15
Metabolomics as an Important Tool for Determining the Mechanisms of Human Skeletal Muscle Deconditioning
Isabelle Alldritt, Paul L. Greenhaff, Daniel J. Wilkinson
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13575-13575
Open Access | Times Cited: 14
Untargeted Metabolomics Reveals Intestinal Pathogenesis and Self-Repair in Rabbits Fed an Antibiotic-Free Diet
Tao Tang, Ya Li, Jie Wang, et al.
Animals (2021) Vol. 11, Iss. 6, pp. 1560-1560
Open Access | Times Cited: 13
Defining NASH from a Multi-Omics Systems Biology Perspective
Lili Niu, Karolina Sulek, Catherine G. Vasilopoulou, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 20, pp. 4673-4673
Open Access | Times Cited: 13
Serum metabolome alterations in patients with early nonalcoholic fatty liver disease
Xuemei Wang, Benchen Rao, Haiyu Wang, et al.
Bioscience Reports (2022) Vol. 42, Iss. 10
Open Access | Times Cited: 9
Amplifying hepatic L-aspartate levels suppresses CCl4-induced liver fibrosis by reversing glucocorticoid receptor β-mediated mitochondrial malfunction
Rui Su, Huiling Fu, Qian-Xue Zhang, et al.
Pharmacological Research (2024) Vol. 206, pp. 107294-107294
Open Access | Times Cited: 1
Differential metabolites in cirrhotic patients with hepatitis B and muscle mass loss
Xuechun Liu, Lei Han, Shenghua Bi, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 4
A Metabolomic Study on the Intervention of Traditional Chinese Medicine Qushi Huayu Decoction on Rat Model of Fatty Liver Induced by High-Fat Diet
Xiao-jun Gou, Shanshan Gao, Liang Chen, et al.
BioMed Research International (2019) Vol. 2019, pp. 1-14
Open Access | Times Cited: 13
Application of metabolomics in the diagnosis of non-alcoholic fatty liver disease and the treatment of traditional Chinese medicine
Mingmei Shao, Yifei Lü, Hongjiao Xiang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Non-invasive urinary metabolomic profiles discriminate biliary atresia from infantile hepatitis syndrome
Weiwei Li, Yan Yang, Qigang Dai, et al.
Metabolomics (2018) Vol. 14, Iss. 7
Closed Access | Times Cited: 12
Overexpression of the Vitronectin V10 Subunit in Patients with Nonalcoholic Steatohepatitis: Implications for Noninvasive Diagnosis of NASH
Maria Del Ben, Diletta Overi, Licia Polimeni, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 2, pp. 603-603
Open Access | Times Cited: 10
Application of Metabolomics in Diagnosis and Treatment of Chronic Liver Diseases
Jie Tang, Kai Xiong, Tong Zhang, et al.
Critical Reviews in Analytical Chemistry (2020) Vol. 52, Iss. 5, pp. 906-916
Closed Access | Times Cited: 9
Prediction of Liver Weight Recovery by an Integrated Metabolomics and Machine Learning Approach After 2/3 Partial Hepatectomy
Runbin Sun, Haokai Zhao, Shu‐Zhen Huang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 8
Untargeted serum metabolites profiling in high-fat diet mice supplemented with enhanced palm tocotrienol-rich fraction using UHPLC-MS
Danial Efendy Goon, Sharaniza Ab‐Rahim, Amir Hakimi Mohd Sakri, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 7
Untargeted metabolomic profiling of urine from healthy dogs and dogs with chronic hepatic disease
Yuri A. Lawrence, Blake C. Guard, Jörg M. Steiner, et al.
PLoS ONE (2019) Vol. 14, Iss. 5, pp. e0217797-e0217797
Open Access | Times Cited: 7
Metabolic impact of partial hepatectomy in the non-alcoholic steatohepatitis animal model of methionine-choline deficient diet
Eugenia Carril, M. Pilar Valdecantos, Borja Lanzón, et al.
Journal of Pharmaceutical and Biomedical Analysis (2019) Vol. 178, pp. 112958-112958
Open Access | Times Cited: 7
RETRACTED: The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD)
Lucia Carulli, Giulia Zanca, Filippo Schepis, et al.
Metabolites (2019) Vol. 9, Iss. 2, pp. 25-25
Open Access | Times Cited: 6
Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome
Carolina Castillo-Castro, Alexandro José Martagón-Rosado, Rocío Ortiz‐López, et al.
World Journal of Hepatology (2021) Vol. 13, Iss. 11, pp. 1494-1511
Open Access | Times Cited: 6
Serum metabolomics analysis in patients with alcohol dependence
Yanjie Zhang, Yajun Sun, Miao Qin, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 2
Identification of Plasmatic Biomarkers of Foie Gras Qualities in Duck by Metabolomics
Zohre Mozduri, Nathalie Marty-Gasset, Bara Lo, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 5
Aqueous Metabolite Trends for the Progression of Nonalcoholic Fatty Liver Disease in Female Bariatric Surgery Patients by Targeted 1H-NMR Metabolomics
Emma Robinson, Matthew C. Taddeo, Xin Chu, et al.
Metabolites (2021) Vol. 11, Iss. 11, pp. 737-737
Open Access | Times Cited: 5
Exploring serum bile acids as potential noninvasive biomarkers for nonalcoholic fatty liver disease
Ashraf A. Basuni, Dina Sweed, Mohammed Fathey Elgazzar, et al.
Egyptian Liver Journal (2024) Vol. 14, Iss. 1
Open Access
From Transcriptomic to Metabolomic in the Development of Biomarkers in NAFLD/NASH
George Dedoussis, Athina I. Amanatidou
Springer eBooks (2020), pp. 181-190
Closed Access | Times Cited: 4
Metabolomic Analysis Identifies Glycometabolism Pathways as Potential Targets of Qianggan Extract in Hyperglycemia Rats
Mingzhe Zhu, Meng Li, Wenjun Zhou, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 4
Integrative proteomics and metabolomics explore the effect and mechanism of Qiyin granules on improving nonalcoholic fatty liver disease
Xuehua Yan, Hongbing Liu, Meng Huang, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27075-e27075
Open Access

Scroll to top